MISSISSAUGA, ONTARIO -- (MARKET WIRE) -- March 08, 2007 -- BioSyent Inc. ("BioSyent") (TSX VENTURE: RX) today released a summary of its 2006 financial results. Sales for the year ended December 31, 2006 were $1,514,491 an increase of 107% compared to the same period in 2005 ($729,707). Operating income (defined as income from operations which excludes interest income and income from extraordinary or one-time events) for the 2006 fiscal year was $356,815, an increase of $476,027 from a fiscal 2005 operating loss of $119,212.
